Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget

doi:10.4253/wjge.v14.i2.85

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5295)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

330

WORD

HTML

2195

Figures (1-3)

334

Tables (1-1)

315

Sum=3248

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

308

Download

335

Sum=643

Publishing Process of This Article

Item

Count

Browse

437

Download

967

Sum=1404

Feb 16, 2022 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Endosc. Feb 16, 2022; 14(2): 85-95
Published online Feb 16, 2022. doi: 10.4253/wjge.v14.i2.85

Open in New Tab Full Size Figure Download Figure

Figure 1 Physiological mechanism. IBD: Inflammatory bowel disease; LGD: Low-grade dysplasia; HGD: High-grade dysplasia.

Open in New Tab Full Size Figure Download Figure

Figure 2 Colorectal cancer risk. CRC: Colorectal cancer; UC: Ulcerative colitis; CD: Crohn disease; PSC: Primary sclerosing cholangitis.

Open in New Tab Full Size Figure Download Figure

Figure 3 Algorithm for the management of dysplasia. Review all dysplasia with 2 experienced GI pathology. LDG: Low-grade dysplasia; HGD: High-grade dysplasia.

Citation: Núñez F P, Quera R, Rubin DT. Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget. World J Gastrointest Endosc 2022; 14(2): 85-95
URL: https://www.wjgnet.com/1948-5190/full/v14/i2/85.htm
DOI: https://dx.doi.org/10.4253/wjge.v14.i2.85